AstraZeneca
Trials will have ups and downs, say scientists
Adverse effects were noted on two human subjects who volunteered for the phase 3 trials of AstraZeneca COVID-19 vaccine
DCGI issues notice to Serum Institute over AstraZeneca's trial suspension
DGCI sought an immediate reply, saying else "it shall be construed that you have no explanation to offer and action will be taken"
AstraZeneca pauses COVID-19 vaccine trial after unexplained illness
AstraZeneca is one of nine companies currently in late-stage Phase 3 trials for their COVID-19 vaccine candidates
Two volunteers who were given Oxford vaccine are fine
The vaccine trials are being conducted by the Serum Institute of India in Pune
Coronavirus vaccine should be mandatory in Australia: PM
Anticipating a backlash from vocal anti-vaccine activists, Morrison said the stakes were too high to allow the disease to continue unchecked
India's Wockhardt to supply COVID-19 vaccines to UK
UK government reserved one fill-and-finish production line at Wockhardt subsidiary in Wrexham, Wales for exclusive use for next 18 months
Five key takeaways from Monday's data on experimental coronavirus vaccines
Oxford University and AstraZeneca announced their vaccine's success in inducing immune responses in volunteers without causing side effects
Russia to mass-produce its experimental COVID-19 vaccine
The first human trial of the vaccine, a month-long test on 38 people, ended this week, and Phase III trial is set to begin in August
Race for virus vaccine could leave some countries behind
Rich countries are rushing to place advance orders for the inevitably limited supply to guarantee their citizens get immunized first
AstraZeneca approaches Gilead about potential merger
Gilead, AstraZeneca and several other drugmakers are racing to develop vaccines for COVID-19